National Health Investors (NHI) Net Equity Issued and Repurchased (2015 - 2025)

National Health Investors' Net Equity Issued and Repurchased history runs 9 years deep, the most recent figure standing at $46.6 million for Q4 2025.

• Quarterly Net Equity Issued and Repurchased fell 67.27% year-over-year to $46.6 million in Q4 2025, while the trailing twelve-month figure through Mar 2026 was $116.0 million (down 44.17% YoY) and the FY2025 annual result came in at $181.5 million, up 27.49% from the prior year.
• Net Equity Issued and Repurchased was $46.6 million for Q4 2025 at National Health Investors, up from $11.4 million in the prior quarter.
• Across five years, Net Equity Issued and Repurchased topped out at $142.4 million in Q4 2024 and bottomed at -$47000.0 in Q2 2021.
• A 3-year average of $53.1 million and a median of $48.0 million in 2021 frame the typical range for Net Equity Issued and Repurchased.
• Annual changes were most pronounced in 2021 — Net Equity Issued and Repurchased soared 55216.09% — and 2025, when it slumped 67.27%.
• National Health Investors' Net Equity Issued and Repurchased stood at -$47000.0 in 2021, then surged by 303065.96% to $142.4 million in 2024, then slumped by 67.27% to $46.6 million in 2025.
• Business Quant data shows NHI's Net Equity Issued and Repurchased at $46.6 million in Q4 2025, $11.4 million in Q3 2025, and $58.0 million in Q2 2025.